Hims & Hers Shares Fall on Quarterly Loss and Missed Sales Expectations
Hims & Hers Health Inc. shares declined after the company reported its quarterly financial results. The company fell short of expected sales figures and reported a loss for the period, shaking investor confidence and leading to a drop in the stock price.
According to the company's financial report, quarterly sales revenue lagged behind analyst estimates. Additionally, the net loss exceeded expectations. These results heightened concerns that the company's growth momentum is slowing.
Hims & Hers operates primarily in the tele-health and personal care products space. The company has recently faced increased competition and rising marketing costs, which have pressured profitability.
Analysts suggest that the company needs to focus on cost control and growth strategies in the coming period. Otherwise, they warn that the stock's performance could weaken further.
This is not investment advice.
📊 HIMS — Piyasa Yorumu
▼ down · 70%The news headline paints a negative picture, indicating that the company missed its quarterly loss and sales expectations. Although the RSI is approaching the overbought zone at 65, the MACD is still giving an upward signal. However, following the 8.6% rise in the last closing session, this negative news could trigger profit-taking in the short term. While being above the SMA20 and SMA50 supports the medium-term trend, the price is likely to test these levels due to the impact of the news. Therefore, a downward movement is expected in the short term.
RSI 14
65.4
MACD
0.86
24h Δ
8.59%
Canlı Grafikler
🔗 İlgili haberler
⭐ 67 · 1 gün önce
Hims & Hers Health Hisseleri Sert Düşüş Yaşadı
⭐ 85 · 1 gün önce
Under Armour Tahmini Eksik, Wendy's Özel Teklif, Hims & Hers Kayıp
⭐ 85 · 1 gün önce
Hims & Hers hisseleri, markalı zayıflama ilacına geçişin etkisiyle düşüşte
⭐ 67 · 1 gün önce
Hims & Hers Hisseleri Düşüşte: Beklenmedik Kazanç Raporu Piyasayı Şaşırttı
⭐ 75 · 2 gün önce
Hims & Hers Gelir Beklentiyi Kaçırdı: ABD İşleri Zayıf, Kullanıcı Harcamaları Düşük
⭐ 75 · 2 gün önce
Hims & Hers Health Inc. Q1 Satışları Rekabet Artışıyla Yetersiz
🧬 Buna benzer
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.